首页> 外文期刊>Journal of Biomolecular Structure and Dynamics >Molecular modelling of human 5-hydroxytryptamine receptor (5-HT2A) and virtual screening studies towards the identification of agonist and antagonist molecules
【24h】

Molecular modelling of human 5-hydroxytryptamine receptor (5-HT2A) and virtual screening studies towards the identification of agonist and antagonist molecules

机译:人5-羟色胺受体(5-HT2A)的分子建模和用于筛选激动剂和拮抗剂分子的虚拟筛选研究

获取原文
获取原文并翻译 | 示例
           

摘要

The serotonin receptors, also known as 5-hydroxytryptamine (5-HT) receptors, are a group of G protein-coupled receptors (GPCRs) and ligand-gated ion channels found in the central and peripheral nervous systems. GPCRs have a characteristic feature of activating different signalling pathways upon ligand binding and these ligands display several efficacy levels to differentially activate the receptor. GPCRs are primary drug targets due to their central role in several signal transduction pathways. Drug design for GPCRs is also most challenging due to their inherent promiscuity in ligand recognition, which gives rise to several side effects of existing drugs. Here, we have performed the ligand interaction study using the two prominent states of GPCR, namely the active and inactive state of the 5-HT2A receptor. Active state of 5-HT2A receptor model enhances the understanding of conformational difference which influences the ligand-binding site. A 5-HT2A receptor active state model was constructed by homology modelling using active state (2)-adrenergic receptor ((2)-AR). In addition, virtual screening and docking studies with both active and inactive state models reveal potential small molecule hits which could be considered as agonist-like and antagonist-like molecules. The results from the all-atom molecular dynamics simulations further confirmed that agonists and antagonists interact in different modes with the receptor.
机译:血清素受体,也称为5-羟色胺(5-HT)受体,是在中枢神经系统和周围神经系统中发现的一组G蛋白偶联受体(GPCR)和配体门控离子通道。 GPCR具有在配体结合后激活不同信号通路的特征,这些配体显示出几种差异激活受体的功效水平。 GPCR由于其在几种信号转导途径中的核心作用而成为主要的药物靶标。 GPCR的药物设计也最具挑战性,因为它们在配体识别方面固有的混杂性,这会引起现有药物的多种副作用。在这里,我们使用GPCR的两个突出状态(即5-HT2A受体的活跃状态和非活跃状态)进行了配体相互作用研究。 5-HT 2A受体模型的活性状态增强了对影响配体结合位点的构象差异的理解。通过使用活动状态(2)-肾上腺素能受体((2)-AR)进行同源性建模,构建了5-HT2A受体活动状态模型。此外,对有活性和无活性状态模型的虚拟筛选和对接研究均揭示了潜在的小分子命中现象,可以将其视为激动剂样和拮抗剂样分子。全原子分子动力学模拟的结果进一步证实,激动剂和拮抗剂与受体相互作用的方式不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号